Skip to content
HowShorted

ANAVEX LIFE SCIENCES CORP. short interest in 2023

In 2023, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 23.56% of shares outstanding on 13 Jan 2023 to 24.45% on 29 Dec 2023, a change of +0.89 percentage points. The year's high was 24.45% on 29 Dec 2023 and its low 18.44% on 28 Apr 2023, averaging 21.23% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.17 days on 31 Aug 2023. Full history: ANAVEX LIFE SCIENCES CORP..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ANAVEX LIFE SCIENCES CORP. in 2023

2023 in figures

Start of year
23.56% (13 Jan 2023)
End of year
24.45% (29 Dec 2023)
Change
+0.89 pp
High
24.45% (29 Dec 2023)
Low
18.44% (28 Apr 2023)
Average
21.23%
Highest days to cover
27.17 (31 Aug 2023)
SEC filings marked
4

Every report in 2023

ANAVEX LIFE SCIENCES CORP. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 202323.56%12.21
31 Jan 202321.45%14.81
15 Feb 202321.97%14.7510-Q filed
28 Feb 202320.93%19.19
15 Mar 202320.11%13.38
31 Mar 202320.38%12.45
14 Apr 202320.00%15.89
28 Apr 202318.44%18.02
15 May 202319.67%16.9710-Q filed
31 May 202320.42%21.63
15 Jun 202321.94%15.22
30 Jun 202320.71%14.58
14 Jul 202320.69%26.84
31 Jul 202320.46%24.62
15 Aug 202320.40%15.5510-Q filed
31 Aug 202320.60%27.17
15 Sep 202320.85%15.56
29 Sep 202321.92%20.26
13 Oct 202321.73%24.58
31 Oct 202322.71%19.02
15 Nov 202322.11%18.54
30 Nov 202321.89%13.6410-K filed
15 Dec 202322.08%17.35
29 Dec 202324.45%11.37

See also: ANAVEX LIFE SCIENCES CORP.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.